MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-10673

  1. 5,630 Posts.
    lightbulb Created with Sketch. 2034
    Yeah, I saw this article and thought, wow: can't wait till everyone sees our results! Bring on that NEJM article.

    We can't get an EUA, that is only for public health emergencies. Accelatory Approval with confirmatory trial is possible. Even if we don't get that, and have to wait for another trial, we know these results are fantastic and so this indiction will move forward. We know that no treatment has ever shown this kind of promise. We know this is blockbuster.

    Everyone reading this also knows this is my bullish opinion and should not be taken as investment advice. Never risk more than you can afford to lose.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.